HeartMate® II continuous-flow left ventricular assist system

Expert Review of Medical Devices

Volumn 8, Issue 1, 2011, Pages 11-21

  Sheikh, Farooq H ^a   Russell, Stuart D ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

bridge to transplantation; destination therapy; heart failure; HeartMate II; left ventricular assist device system; mechanical circulatory support

Indexed keywords

ADVERSE EVENTS; CIRCULATORY SUPPORT; CLINICAL OUTCOME; CONTINUOUS-FLOW; DESTINATION THERAPY; HEART FAILURE; LEFT VENTRICULAR; LEFT VENTRICULAR ASSIST DEVICES; LEFT VENTRICULAR ASSIST SYSTEMS; MECHANICAL CIRCULATORY SUPPORT; TEMPORARY SUPPORT; THERAPEUTIC STRATEGY;

CARDIOLOGY; HEART;

EQUIPMENT;

AORTA BALLOON; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DEVICE INFECTION; FUNCTIONAL STATUS; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE ASSIST DEVICE; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; KIDNEY FAILURE; NEUROLOGIC DISEASE; OVERALL SURVIVAL; PROGNOSIS; QUALITY OF LIFE; REOPERATION; RESPIRATORY FAILURE; REVIEW; SEPSIS; SURVIVAL RATE; THROMBOSIS; UREA NITROGEN BLOOD LEVEL;

CLINICAL TRIALS AS TOPIC; DATABASES AS TOPIC; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMORHEOLOGY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; VENTRICULAR FUNCTION;

EID: 78650409758     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.10.77     Document Type: Review

References (40)

1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119, 480-486 (2009).
2. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J. Am. Coll. Cardiol. 52, 428-434 (2008).
3. Lund LH, Matthews J, Aaronson K. Patient selection for left ventricular assist devices. Eur. J. Heart. Fail. 12, 434-443 (2010).
4. Jessup M, Brozena S. Heart failure. N. Engl. J. Med. 348, 2007-2018 (2003).
5. Taylor DO, Stehlik J, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report-2009. J. Heart Lung Transplant. 28, 1007-1022 (2009).
6. Hershberger RE, Nauman D, Walker TL, Dutton D, Burgess D. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J. Card. Fail. 9, 180-187 (2003).
7. Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J. Am. Coll. Cardiol. 50, 741-747 (2007).
8. Gorodeski EZ, Chu EC, Reese JR, Shishehbor MH, Hsich E, Starling RC. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Circ. Heart Fail. 2, 320-324 (2009).
9. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J. Heart Lung Transplant. 29, 1-10 (2010).
10. Kirklin J, Frazier O. Developmental History of Mechanical Circulatory Support. In: Mechanical Circulatory Support. Elsevier, London, UK (2006).
11. DeBakey ME. Left ventricular bypass pump for cardiac assistance. Clinical experience. Am. J. Cardiol. 27, 3-11 (1971).
12. Akutsu T, Mirkovitch V, Topaz SR, Kolff WJ. Silastic sac type of artifical heart and its use in calves. Trans. Am. Soc. Artif. Intern. Organs 9, 281-285 (1963).
13. Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am. J. Cardiol. 24, 723-730 (1969).
14. DeVries WC. The permanent artificial heart. Four case reports. JAMA 259, 849-859 (1988).
15. DeVries WC, Anderson JL, Joyce LD, et al. Clinical use of the total artificial heart. N. Engl. J. Med. 310, 273-278 (1984).
16. Copeland JG, Smith R, Icenogle T, et al. Orthotopic total artificial heart bridge to transplantation: preliminary results. J. Heart Transplant. 8, 124-137 (1989).
17. McCarthy PM, Portner PM, Tobler HG, Starnes VA, Ramasamy N, Oyer PE. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application. J. Thorac. Cardiovasc. Surg. 102, 578-586 (1991).
18. Hill JD, Farrar DJ, Hershon JJ, et al. Use of a prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N. Engl. J. Med. 314, 626-628 (1986).
19. Boilson BA, Raichlin E, Park SJ, Kushwaha SS. Device therapy and cardiac transplantation for end-stage heart failure. Curr. Probl. Cardiol. 35, 8-64 (2010).
20. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N. Engl. J. Med. 345, 1435-1443 (2001).
21. Goldstein D, Zucker M, Pagani FD, Frazier OH. Rotary Ventricular Assist Devices. In: Mechanical Circulatory Support. Kirklin JK FO (Ed.). ISHLT Monograph Series, Elsevier, London, UK, 84-92 (2006).
22. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J. Heart Lung Transplant. 29, S1-S39 (2010).
23. Birks EJ. Left ventricular assist devices. Heart 96, 63-71 (2010).
24. Baughman KL, Jarcho JA. Bridge to life-cardiac mechanical support. N. Engl. J. Med. 357, 846-849 (2007).
25. Heartmate II LVAS: Instructions For Use. Thoratec Corporation, Pleasanton, CA, USA (2008).
26. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N. Engl. J. Med. 357, 885-896 (2007).
27. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J. Am. Coll. Cardiol. 54, 312-321 (2009).
28. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N. Engl. J. Med. 361, 2241-2251 (2009).
29. Rogers JG, Aaronson KD, Boyle AJ, et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J. Am. Coll. Cardiol. 55, 1826-1834 (2010).
30. Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J. Thorac. Cardiovasc. Surg. 139(5), 1316-1324 (2010).
31. Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J. Heart Lung Transplant. 28, 881-887 (2009).
32. Kamdar F, Boyle A, Liao K, et al. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J. Heart Lung Transplant. 28, 352-359 (2009).
33. Russell SD, Rogers JG, Milano CA, et al. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120, 2352-2357 (2009).
34. Crow S, John R, Boyle A, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J. Thorac. Cardiovasc. Surg. 137, 208-215 (2009).
35. Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J. Am. Coll. Cardiol. 53, 2162-2167 (2009).
36. Geisen U, Heilmann C, Beyersdorf F, et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur. J. Cardiothorac. Surg. 33, 679-684 (2008).
37. Mudd JO, Cuda JD, Halushka M, et al. Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J. Heart Lung Transplant. 27, 1269-1274 (2008).
38. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH. End-organ function in patients on long-term circulatory support with continuous-or pulsatile-flow assist devices. J. Heart Lung Transplant. 26, 815-818 (2007).
39. den Uil CA, Maat AP, Lagrand WK, et al. Mechanical circulatory support devices improve tissue perfusion in patients with end-stage heart failure or cardiogenic shock. J. Heart Lung Transplant. 28, 906-911 (2009).
40. Thoratec Corporation www.thoratec.com/medical-professionals/ resource-library/ifus-manuals/heartmate-ll-lvad.aspx